GH_PushbackThumbnail-02 Courtesy: Gateway House
10 August 2017

Geoeconomic pushback to China

The Indian government may block the acquisition of Gland Pharma by Shanghai Fosun Pharmaceuticals, a move that offers further confirmation of how China’s opaque business model is causing concern worldwide. This infographic shows some high-profile cases of acquisitions by Chinese companies that ran into local opposition

China-SriLanka-Title Card Courtesy: Gateway House
1 December 2016

Chinese investments in Sri Lanka

China is the largest investor in Sri Lanka today, with funding and investment of nearly $15 billion. Gateway House tracks the Chinese money trail to Sri Lanka-- where it lands, where it stays--and assesses its depth. This is the second in the Gateway House Series on Chinese investments in South Asia.